P53 functional mutation type in high-grade serous ovarian cancer and clinical outcomes.

被引：0
|
作者：
Mandilaras, Victoria
Garg, Swati
Burnier, Julia
Karakasis, Katherine
Wang, Lisa
Mackay, Helen
Dhani, Neesha C.
Butler, Marcus O.
Rodriguez-Freixinos, Victor
Wilson, Michelle K.
Martin-Lorente, Cristina
Ethier, Josee-Lyne
Bedard, Philippe L.
Siu, Lillian L.
Clarke, Blaise
Shaw, Patricia Ann
Stockley, Tracy
Oza, Amit M.
Lheureux, Stephanie
机构：
[1] Univ Hlth Network, Princess Margaret Canc Ctr, Div Med Oncol & Hematol, Toronto, ON, Canada
[2] Univ Hlth Network, Dept Pathol, Toronto, ON, Canada
[3] Princess Margaret Canc Ctr, Toronto, ON, Canada
[4] Univ Hlth Network, Toronto, ON, Canada
[5] Princess Margaret Canc Ctr, Dept Biostatist, Toronto, ON, Canada
[6] Univ Toronto, Toronto, ON, Canada
[7] Univ Hlth Network, Dept Pathol & Lab Med, Toronto, ON, Canada
[8] Univ Hlth Network, Lab Med Program, Genome Diagnost, Toronto, ON, Canada
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2016年 / 34卷 / 15期
关键词：
D O I：
10.1200/JCO.2016.34.15_suppl.5550
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
5550
引用
收藏
页数：3
相关论文
共 50 条
  • [31] Clinical Outcomes of Patients with High-Grade Ovarian Carcinoma Arising in Endometriosis Compared to Ovarian High-Grade Serous Carcinoma
    Ibrahim Yalcin
    Hanifi Sahin
    Mustafa Erkan Sari
    Asuman Nihan Haberal
    Eda Adeviye Sahin
    Husnu Celik
    Mehmet Mutlu Meydanli
    Ali Ayhan
    Indian Journal of Gynecologic Oncology, 2021, 19
  • [32] Clinical Outcomes of Patients with High-Grade Ovarian Carcinoma Arising in Endometriosis Compared to Ovarian High-Grade Serous Carcinoma
    Yalcin, Ibrahim
    Sahin, Hanifi
    Sari, Mustafa Erkan
    Haberal, Asuman Nihan
    Sahin, Eda Adeviye
    Celik, Husnu
    Meydanli, Mehmet Mutlu
    Ayhan, Ali
    INDIAN JOURNAL OF GYNECOLOGIC ONCOLOGY, 2021, 19 (04)
  • [33] The fading guardian: clinical relevance of TP53 null mutation in high-grade serous ovarian cancers
    Biatta, Chiara M.
    Paudice, Michele
    Greppi, Marco
    Parrella, Veronica
    Parodi, Alessia
    De Luca, Giuseppa
    Cerruti, Gianna Maria
    Mammoliti, Serafina
    Caroti, Cinzia
    Menichini, Paola
    Fronza, Gilberto
    Pesce, Silvia
    Marcenaro, Emanuela
    Vellone, Valerio G.
    FRONTIERS IN IMMUNOLOGY, 2023, 14
  • [34] High-grade serous carcinoma with discordant p53 signature: report of a case with new insight regarding high-grade serous carcinogenesis
    Hatano, Yuichiro
    Fukuda, Shinya
    Makino, Hiroshi
    Tomita, Hiroyuki
    Morishige, Ken-ichirou
    Hara, Akira
    DIAGNOSTIC PATHOLOGY, 2018, 13
  • [35] High-grade serous carcinoma with discordant p53 signature: report of a case with new insight regarding high-grade serous carcinogenesis
    Yuichiro Hatano
    Shinya Fukuda
    Hiroshi Makino
    Hiroyuki Tomita
    Ken-ichirou Morishige
    Akira Hara
    Diagnostic Pathology, 13
  • [36] Functional Homologous Recombination Assay on FFPE Specimens of Advanced High-Grade Serous Ovarian Cancer Predicts Clinical Outcomes
    Pikkusaari, Sanna
    Tumiati, Manuela
    Virtanen, Anni
    Oikkonen, Jaana
    Li, Yilin
    Perez-Villatoro, Fernando
    Muranen, Taru
    Salko, Matilda
    Huhtinen, Kaisa
    Kanerva, Anna
    Koskela, Heidi
    Tapper, Johanna
    Koivisto-Korander, Riitta
    Joutsiniemi, Titta
    Haltia, Ulla-Maija
    Lassus, Heini
    Hautaniemi, Sampsa
    Farkkila, Anniina
    Hynninen, Johanna
    Hietanen, Sakari
    Carpen, Olli
    Kauppi, Liisa
    CLINICAL CANCER RESEARCH, 2023, 29 (16) : 3110 - 3123
  • [37] Thrombocytosis and hyperfibrinogenemia are predictive factors of clinical outcomes in high-grade serous ovarian cancer patients
    Feng, Zheng
    Wen, Hao
    Bi, Rui
    Duan, Yachen
    Yang, Wentao
    Wu, Xiaohua
    BMC CANCER, 2016, 16
  • [38] Prevalence of viral DNA in high-grade serous epithelial ovarian cancer and correlation with clinical outcomes
    Robertson, Sharon E.
    Yasukawa, Maya
    Marchion, Douglas C.
    Xiong, Yin
    Naqvi, Syeda Mahrukh Hussnain
    Gheit, Tarik
    Tommasino, Massimo
    Wenham, Robert M.
    Giuliano, Anna R.
    Lancaster, Johnathan M.
    Shahzad, Mian M. K.
    PLOS ONE, 2023, 18 (12):
  • [39] Thrombocytosis and hyperfibrinogenemia are predictive factors of clinical outcomes in high-grade serous ovarian cancer patients
    Zheng Feng
    Hao Wen
    Rui Bi
    Yachen Duan
    Wentao Yang
    Xiaohua Wu
    BMC Cancer, 16
  • [40] Immunobiology of high-grade serous ovarian cancer: lessons for clinical translation
    Lana E. Kandalaft
    Denarda Dangaj Laniti
    George Coukos
    Nature Reviews Cancer, 2022, 22 : 640 - 656
12345